AGAdam GehringPhDVideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2017Innate Immunity : TLR, RIG-I, STING and potential others | Adam Gehring, PhDView Video
MMMala MainiMD, PhDVideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2017How does HBV interact with the immune system | Mala Maini, MD, PhDView Video
HJHarry JanssenMD, PhDVideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2017Is immunomodulation really needed to cure HBV? | Harry Janssen, MD, PhDView Video
FZFabien ZoulimMD, PhDVideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2017Hepatitis B Cure: From Discovery to Regulatory Endpoints in HBV clinical research: A summary of the AASLD/EASL statement | Fabien Zoulim, MD, PhDView Video
PLPietro LamperticoMD, PhDVideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2017TAF – The latest update, which questions remain to be answered? | Pietro Lampertico, MD, PhDView Video
JFJordan FeldMD, MPHSlidesetViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2017Combination therapy how to navigate in a minefield of efficacy and toxicity?- Jordan Feld, MD, MPHView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2017Innovative trial design- Henry Lik Yuen ChanView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2017Other virological mechanisms- Stephen Locarnini, BSc, PhD, MBBS, FRCPView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2017RNA interference- Bill Symonds, PharmDView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2017HBV Ribonuclease H- John Tavis, PhDView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2017CCC – DNA inhibition- Anuj Gaggar, MD, PhDView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2017Entry inhibition- Stephan Urban, PhDView Slideset